Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Watchdog makes 'preliminary enquiries' into shortages

The government's competition watchdog – the Competition Markets Authority (CMA) – says shortages are "not yet under consideration" for a formal investigation.

EXCLUSIVE

The government’s competition watchdog may investigate stock shortages using information from C+D readers.

The Competition and Markets Authority (CMA) said it is making “preliminary enquiries” into the reasons for stock shortages and last week (August 11) requested C+D’s 2012 and 2013 reports on the issue. 

The issue “is not yet under consideration” for a formal investigation, the watchdog said.

When asked why it was making enquiries, the CMA told C+D it “routinely monitors intelligence from a range of sources about markets from the whole economy”. It declined to comment on when it will decide whether or not to carry out the investigation.

Pharmacy Voice said it is already in “active discussions” with the CMA to help the watchdog “fully understand the problems in the supply chain and the negative impact on patients and pharmacies”.

“There is plenty of evidence that medicines shortages are a problem,” Pharmacy Voice spokesperson Gareth Jones told C+D last Friday (August 14).

The CMA asked C+D for a report it compiled on stock shortages in 2013, to help with its enquiries.

In the report, which was submitted to the Department of Health, C+D found that readers were spending an average of two working days a month trying to source out-of-stock medicines. In six out of 10 cases, manufacturers were breaching government guidelines that state that pharmacists should receive medicines within 24 hours of ordering them, C+D found.

In 2009, Scottish pharmacists urged CMA’s predecessor the Office of Fair Trading (OFT) to investigate shortages caused by direct-to-pharmacy and restricted wholesaler models.

 

 
How could a government investigation into stock shortages benefit the sector?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics

         
Pharmacy Manager
Guernsey
£70,000

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007629

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel